Financials
- Market Capitalization 38.33 M
- Employee 17
- Founded 2009
- CEO N/A
- Website www.renovorx.com
- Headquarter Delaware, United States
- FIGI BBG005XWWZK6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4373 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.73 USD | +15.33% | +16.89% | -15.61% | -57.60% | 41.39 M USD | ||
| 4382 | GRCE Grace Therapeutics, Inc. - Common Stock | 2.46 USD | +1.23% | -1.60% | +10.81% | -38.19% | 40.03 M USD | ||
| 4394 | NNVC NanoViricides, Inc. Common Stock | 1.77 USD | +7.27% | +19.59% | +24.65% | +75.23% | 38.32 M USD | ||
| 4398 | ALGS Aligos Therapeutics, Inc. - Common stock | 6.11 USD | -3.93% | +3.21% | +20.28% | -37.59% | 37.81 M USD |
Frequently asked questions about RenovoRx, Inc. - Common Stock
What is the RenovoRx, Inc. - Common Stock stock price today?
The current price of RenovoRx, Inc. - Common Stock (RNXT) is 0.85. Over the past 24 hours, the stock has changed by -6.59%. Follow the RNXT chart for real-time price dynamics.
What is the stock ticker of RenovoRx, Inc. - Common Stock?
RenovoRx, Inc. - Common Stock trades under the ticker RNXT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is RenovoRx, Inc. - Common Stock stock going up?
RNXT has changed by -7.61% over the last week, -3.41% over the last month, and -35.61% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was RenovoRx, Inc. - Common Stock net income for the last quarter?
RenovoRx, Inc. - Common Stock reported net income of -3.52 M for the last quarter. The previous quarter showed -2.94 M, which means net income changed by -19.72%.
How many employees does RenovoRx, Inc. - Common Stock have?
As of the latest available data, RenovoRx, Inc. - Common Stock has 17 employees. Workforce size can provide additional context about the company's scale and operations.
What is RenovoRx, Inc. - Common Stock EBITDA?
RenovoRx, Inc. - Common Stock EBITDA is -3.47 M, and its EBITDA margin is -615.99%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy RenovoRx, Inc. - Common Stock stock?
You can buy RenovoRx, Inc. - Common Stock (RNXT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in RenovoRx, Inc. - Common Stock stock?
Investing in RenovoRx, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RNXT chart and related analysis on metatrader.com as part of your research.